Dyne Therapeutics Inc. (DYN)
NASDAQ: DYN
· Real-Time Price · USD
12.24
-0.09 (-0.73%)
At close: Aug 19, 2025, 12:07 PM
Dyne Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 485.04M | 472.25M | 435.45M | 532.16M | 608.2M | 272.04M | 121.63M | 130.28M | 167.61M | 181.11M | 172.15M | 144.9M | 135.98M | 147.97M | 200.82M | 229.04M | 258.38M | 310.95M |
Short-Term Investments | 198.88M | 205.24M | 206.82M | 191.51M | 170.64M | 181.51M | 1.47M | 27.54M | 40.13M | 57.1M | 83.86M | 103.24M | 155.86M | 175.19M | 175.75M | 178.48M | 177.2M | 172.14M |
Long-Term Investments | n/a | n/a | n/a | n/a | 1.93M | -181.33M | 2.31M | 2.33M | 2.32M | 2.32M | 2.32M | 2.32M | 2.31M | 2.31M | 2.31M | 2.31M | 2.88M | 2.3M |
Other Long-Term Assets | 2.51M | 1.94M | 1.94M | 1.94M | n/a | 183.25M | n/a | 10.39M | n/a | 11M | 9.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 14.03M | 12.01M | 17.01M | 12.72M | 13.48M | 34.59M | 6.28M | 10.39M | 5.44M | 11M | 9.58M | n/a | 6.1M | 21.3M | 5.82M | 17.13M | 25.71M | 3.98M |
Total Current Assets | 697.95M | 689.5M | 659.28M | 736.39M | 792.32M | 488.14M | 129.38M | 157.82M | 213.17M | 238.21M | 256.01M | 258.23M | 297.93M | 344.45M | 382.39M | 424.65M | 461.3M | 487.07M |
Property-Plant & Equipment | 28.53M | 29.63M | 30.01M | 30.52M | 31.64M | 32.22M | 33.39M | 34.7M | 35.92M | 37.11M | 38.41M | 39.13M | 39.78M | 41M | 40.96M | 39.91M | 2.96M | 2.34M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 31.04M | 31.57M | 31.95M | 32.45M | 33.56M | 34.14M | 35.71M | 47.42M | 38.25M | 50.43M | 50.31M | 41.45M | 42.09M | 43.31M | 43.27M | 42.22M | 5.85M | 4.64M |
Total Assets | 728.99M | 721.07M | 691.23M | 768.84M | 825.88M | 522.28M | 165.08M | 205.24M | 251.42M | 288.64M | 306.32M | 299.68M | 340.03M | 387.76M | 425.66M | 466.88M | 467.15M | 491.71M |
Account Payables | 14.02M | 7.02M | 6.56M | 6.16M | 1.89M | 7.21M | 22.94M | 3.55M | 2.72M | 8.77M | 5.26M | 919K | 6.97M | 5.19M | 4.03M | 7.09M | 5.65M | 5.76M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 10.38M | n/a | n/a | n/a | n/a | n/a | n/a | -5.49M | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 5M | n/a | n/a | n/a | 4.78M | n/a | 4.72M | 4.71M | 4.71M | 4.64M | 4.61M | 4.58M | 5.49M | 4.71M | 3.89M | 4.59M | 403K | 596K |
Other Current Liabilities | 22.45M | n/a | n/a | n/a | 10.13M | 5.67M | 8.22M | 10.73M | 4.34M | 1.79M | 7.67M | 8.82M | 4.93M | 7.23M | 11.81M | 4.39M | 6.5M | 5.72M |
Total Current Liabilities | 41.47M | 33.88M | 42.26M | 43.26M | 29.75M | 22.36M | 51.09M | 29.69M | 20.22M | 21.59M | 28.09M | 23.32M | 25.62M | 23.24M | 28.72M | 23.35M | 14.55M | 13.45M |
Long-Term Debt | 17.26M | n/a | n/a | n/a | n/a | n/a | 22.7M | 23.51M | 24.32M | 25.12M | 25.87M | 26.61M | 27.34M | 28.07M | 28.74M | 29.41M | n/a | n/a |
Other Long-Term Liabilities | 98.81M | n/a | n/a | n/a | n/a | n/a | -22.7M | -23.51M | -24.32M | -25.12M | -25.87M | -26.61M | -27.34M | -28.07M | -28.74M | -29.41M | n/a | n/a |
Total Long-Term Liabilities | 116.08M | 18.22M | 19.14M | 20.04M | 20.94M | 21.86M | 22.7M | 23.51M | 24.32M | 25.12M | 25.87M | 26.61M | 27.34M | 28.07M | 28.74M | 29.41M | 8.5M | 7.09M |
Total Liabilities | 157.55M | 52.1M | 61.4M | 63.3M | 50.69M | 44.22M | 73.79M | 53.21M | 44.54M | 46.71M | 53.96M | 49.94M | 52.97M | 51.3M | 57.47M | 52.76M | 14.55M | 13.45M |
Total Debt | 22.26M | 23.33M | 23.99M | 24.86M | 25.72M | 26.62M | 27.41M | 28.23M | 29.04M | 29.76M | 30.48M | 31.19M | 32.83M | 32.78M | 32.64M | 34M | 403K | 596K |
Common Stock | 11K | 11K | 10K | 10K | 10K | 9K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K |
Retained Earnings | -1.18B | -1.07B | -949.93M | -860.39M | -763.26M | -698.16M | -632.51M | -565.87M | -505.66M | -440.76M | -396.57M | -357.75M | -316.36M | -264.06M | -228.47M | -176.69M | -134.11M | -104.15M |
Comprehensive Income | 252K | 241K | 6K | 478K | -240K | -132K | n/a | -13K | -56K | -203K | -571K | -983K | -1.16M | -930K | -269K | -34K | -41K | -68K |
Shareholders Equity | 571.45M | 668.97M | 629.84M | 705.54M | 775.19M | 478.06M | 91.29M | 152.04M | 206.88M | 241.94M | 252.36M | 249.74M | 287.06M | 336.46M | 368.2M | 414.12M | 452.6M | 478.26M |
Total Investments | n/a | 205.24M | 206.82M | 191.51M | 172.57M | 181.51K | 3.79M | 27.54M | 40.13M | 57.1M | 83.86M | 103.24M | 155.86M | 175.19M | 175.75M | 178.48M | 177.2M | 172.14M |